NCT02270957View on ClinicalTrials.gov

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2021

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL

Abatacept

OTHER

Placebo

Trial Locations (1)

73104

Oklahoma Medical Research Foundation, Oklahoma City

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Oklahoma Medical Research Foundation

OTHER